Skip to main content

Table 5 Prognostic utility of MEF50 < 60 % of predicted in patients without COPD

From: Diagnostic and prognostic utility of mid-expiratory flow rate in older community-dwelling persons with respiratory symptoms, but without chronic obstructive pulmonary disease

 

Acute bronchitis

Pneumonia

Hospitalization for pulmonary reasons

Death

Model 1

2.53 (1.28; 5.02) P = 0.008

2.11 (0.99; 4.51) P = 0.054

2.24 (0.94; 5.31) P = 0.07

2.17 (0.83; 5.71) P = 0.11

Model 2

2.54 (1.26; 5.13) P = 0.009

2.14 (0.98; 4.69) P = 0.06

2.28 (0.93; 5.62) P = 0.07

1.84 (0.68; 4.99) P = 0.23

Model 3

3.04 (1.36; 6.79) P = 0.007

2.66 (1.10; 6.40) P = 0.03

3.86 (1.25; 11.9) P = 0.019

1.97 (0.52; 7.36) P = 0.32

  1. Hazard ratios with 95 % confidence intervals from Cox proportional hazard regression are presented. Median follow-up was 4.6 years. MEF50 < 60 % of predicted coded as “1”
  2. Model 1: Unadjusted
  3. Model 2: Adjusted for age and sex
  4. Model 3: Adjusted for age and sex in the subgroup of 128 patients without heart failure
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us